Artal Group S.A.

Holdings History for BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

Symbol: BMRN on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2023			-0.01%	$0	0	-5,028	-100%	$57.18	Q3 2023
30 Jun 2023		0.01%	-0.07%	$436,000	5,028	-26,939	-84%	$86.71	Q2 2023
31 Mar 2023		0.18%	+0.18%	$3,108,000	31,967	+31,967	NEW	$97.23	Q1 2023
30 Jun 2021	call		-1.2%	$0	0	-150,000	-100%	$57.18	Q2 2021
31 Mar 2021	call	1.2%	0%	$11,327,000	150,000	0		$75.51	Q1 2021
31 Dec 2020	call	4.6%	0%	$13,154,000	150,000	0		$87.69	Q4 2020
30 Sep 2020	call	1%	+1%	$11,412,000	150,000	+150,000	NEW	$76.08	Q3 2020
30 Jun 2020	call		-6.1%	$0	0	-200,000	-100%	$57.18	Q2 2020
31 Mar 2020	call	6.1%	+3.1%	$16,900,000	200,000	+100,000	+100%	$84.50	Q1 2020
31 Dec 2019	call	4.4%	+4.4%	$8,455,000	100,000	+100,000	NEW	$84.55	Q4 2019
31 Mar 2019	call		-2.5%	$0	0	-200,000	-100%	$57.18	Q1 2019
31 Dec 2018	call	2.5%	0%	$17,030,000	200,000	0		$85.15	Q4 2018
30 Sep 2018	call	2%	0%	$19,394,000	200,000	0		$96.97	Q3 2018
30 Jun 2018	call	2.1%	0%	$18,840,000	200,000	0		$94.20	Q2 2018
31 Mar 2018	call	1.4%	+0.68%	$16,214,000	200,000	+100,000	+100%	$81.07	Q1 2018
31 Dec 2017			-0.37%	$0	0	-200,000	-100%	$57.18	Q4 2017
31 Dec 2017	call	0.71%	0%	$8,917,000	100,000	0		$89.17	Q4 2017
30 Sep 2017		0.37%	-0.09%	$18,614,000	200,000	-50,000	-20%	$93.07	Q3 2017
30 Sep 2017	call	1.2%	-0.61%	$9,307,000	100,000	-50,000	-33%	$93.07	Q3 2017
30 Jun 2017		0.5%	-0.15%	$22,705,000	250,000	-75,000	-23%	$90.82	Q2 2017
30 Jun 2017	call	1.1%	+0.75%	$13,623,000	150,000	+100,000	+200%	$90.82	Q2 2017
31 Mar 2017		0.74%	-0.06%	$28,529,000	325,000	-25,000	-7.1%	$87.78	Q1 2017
31 Mar 2017	call	0.7%	-1.4%	$4,389,000	50,000	-100,000	-67%	$87.78	Q1 2017
31 Dec 2016		0.78%	+0.11%	$28,994,000	350,000	+50,000	+17%	$82.84	Q4 2016
31 Dec 2016	call	1.5%	+1.5%	$12,426,000	150,000	+150,000	NEW	$82.84	Q4 2016
30 Sep 2016		0.7%	-0.12%	$27,756,000	300,000	-50,000	-14%	$92.52	Q3 2016
30 Jun 2016		0.63%	-0.09%	$27,230,000	350,000	-50,000	-12%	$77.80	Q2 2016
31 Mar 2016		0.72%	+0.23%	$32,992,000	400,000	+125,000	+45%	$82.48	Q1 2016
31 Mar 2016	call		-0.89%	$0	0	-100,000	-100%	$57.18	Q1 2016
31 Dec 2015		0.7%	-0.42%	$28,809,000	275,000	-165,000	-38%	$104.76	Q4 2015
31 Dec 2015	call	0.89%	0%	$10,476,000	100,000	0		$104.76	Q4 2015
30 Sep 2015		1.4%	+0.02%	$46,341,000	440,000	+5,000	+1.1%	$105.32	Q3 2015
30 Sep 2015	call	0.9%	-0.9%	$10,532,000	100,000	-100,000	-50%	$105.32	Q3 2015
30 Jun 2015		4.7%	-0.48%	$59,499,000	435,000	-45,000	-9.4%	$136.78	Q2 2015
30 Jun 2015	call	2.6%	0%	$27,356,000	200,000	0		$136.78	Q2 2015
31 Mar 2015		4.5%	0%	$59,818,000	480,000	0		$124.62	Q1 2015
31 Mar 2015	call	3%	-1.5%	$24,924,000	200,000	-100,000	-33%	$124.62	Q1 2015
31 Dec 2014		2.6%	-0.38%	$43,392,000	480,000	-70,000	-13%	$90.40	Q4 2014
31 Dec 2014	call	2.3%	+0.76%	$27,120,000	300,000	+100,000	+50%	$90.40	Q4 2014
30 Sep 2014		2.5%	+0.11%	$39,688,000	550,000	+25,000	+4.8%	$72.16	Q3 2014
30 Sep 2014	call	1.3%	-1.3%	$14,432,000	200,000	-200,000	-50%	$72.16	Q3 2014
30 Jun 2014		2.4%	0%	$32,660,000	525,000	0		$62.21	Q2 2014
30 Jun 2014	call	2.2%	+1.1%	$24,884,000	400,000	+200,000	+100%	$62.21	Q2 2014
31 Mar 2014		2.5%	+0.59%	$35,810,000	525,000	+125,000	+31%	$68.21	Q1 2014
31 Mar 2014	call	1%	-1.6%	$13,642,000	200,000	-300,000	-60%	$68.21	Q1 2014
31 Dec 2013		1.6%	0%	$28,140,000	400,000	0		$70.35	Q4 2013
31 Dec 2013	call	3.3%	0%	$35,175,000	500,000	0		$70.35	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.